Back to Results
First PageMeta Content
Research / Clinical research / Pharmaceutical industry / Design of experiments / Gene delivery / Jesse Gelsinger / Food and Drug Administration / Clinical trial / Gene therapy / Medicine / Pharmacology / Health


April 2008 NEWS IS PROVIDED FOR YOUR USE AND INFORMATION WITHOUT ENDORSEMENT OR OPINION Article courtesy of Becky Hawkins, ORA BY PAUL GELSINGERAND ADILE SHAMOO
Add to Reading List

Document Date: 2012-08-29 10:11:00

Open Document

File Size: 32,83 KB

Share Result on Facebook

City

Amsterdam / /

Country

Netherlands / /

Event

Person Communication and Meetings / /

Facility

University of Pennsylvania’s IRB / University of Pennsylvania / /

MedicalCondition

schizophrenia / ornithine transcarbamylase deficiency / disorder / /

MedicalTreatment

gene therapy / /

Organization

office of Inspector General / Citizens for Responsible Care and Research / office of Human Research Protections / federal government / Food and Drug Administration / House of Representatives / Recombinant DNA Advisory Committee of the National Institutes of Health / National Institutes of Health Recombinant DNA Advisory Committee / the University of Pennsylvania / United States Department of Justice / Department of Health and Human Services / Senate / /

Person

Alan Milstein / Adil E. Shamoo / SHAMOO EIGHT YEARS AFTER JESSE / Paul Gelsinger / Becky Hawkins / Jesse Gelsinger / ORA BY PAUL GELSINGERAND ADILE / Teen / /

Position

attorney / principal investigator / inspector / representative / /

ProvinceOrState

Pennsylvania / /

Technology

gene therapy / html / Recombinant DNA / pdf / /

URL

http /

SocialTag